|
|
 |
|
Total Number of Holdings (excluding cash): 50
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
5,685 |
$57,791.68 |
2.78% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
212 |
$51,004.57 |
2.46% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$47,909.38 |
2.31% |
| Align Technology, Inc. |
ALGN |
016255101 |
232 |
$47,439.36 |
2.29% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,122 |
$47,417.92 |
2.28% |
| DexCom, Inc. |
DXCM |
252131107 |
553 |
$47,259.38 |
2.28% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,997 |
$47,010.59 |
2.26% |
| Agilent Technologies, Inc. |
A |
00846U101 |
372 |
$46,191.24 |
2.23% |
| Cochlear Limited |
COH.AU |
Q25953102 |
232 |
$46,284.72 |
2.23% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
597 |
$45,670.50 |
2.20% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
37 |
$45,740.88 |
2.20% |
| ResMed Inc. |
RMD |
761152107 |
177 |
$45,678.39 |
2.20% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
850 |
$45,322.00 |
2.18% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
1,873 |
$44,295.31 |
2.13% |
| Insulet Corporation |
PODD |
45784P101 |
148 |
$44,015.20 |
2.12% |
| Hologic, Inc. |
HOLX |
436440101 |
651 |
$43,519.35 |
2.10% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
321 |
$43,462.24 |
2.09% |
| BioMerieux |
BIM.FP |
F1149Y232 |
303 |
$43,093.82 |
2.08% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
545 |
$42,946.00 |
2.07% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
766 |
$42,869.62 |
2.07% |
| Danaher Corporation |
DHR |
235851102 |
206 |
$42,335.06 |
2.04% |
| Stryker Corporation |
SYK |
863667101 |
107 |
$42,240.39 |
2.04% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
183 |
$41,949.09 |
2.02% |
| Boston Scientific Corporation |
BSX |
101137107 |
401 |
$41,647.86 |
2.01% |
| Waters Corporation |
WAT |
941848103 |
118 |
$41,687.04 |
2.01% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
160 |
$41,580.80 |
2.00% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,881 |
$41,083.49 |
1.98% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,655 |
$40,978.66 |
1.97% |
| Masimo Corporation |
MASI |
574795100 |
246 |
$40,914.72 |
1.97% |
| Revvity, Inc. |
RVTY |
714046109 |
400 |
$40,960.00 |
1.97% |
| Medtronic Plc |
MDT |
G5960L103 |
451 |
$40,319.40 |
1.94% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
76 |
$39,979.80 |
1.93% |
| Abbott Laboratories |
ABT |
002824100 |
299 |
$39,946.40 |
1.92% |
| Steris Plc |
STE |
G8473T100 |
171 |
$39,453.12 |
1.90% |
| Baxter International Inc. |
BAX |
071813109 |
1,322 |
$39,263.40 |
1.89% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
132 |
$39,208.07 |
1.89% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
624 |
$38,681.14 |
1.86% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
406 |
$38,639.02 |
1.86% |
| Alcon Inc. |
ALC.SW |
H01301128 |
428 |
$38,289.22 |
1.84% |
| The Cooper Companies, Inc. |
COO |
216648501 |
493 |
$37,813.10 |
1.82% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
87 |
$37,473.51 |
1.81% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
360 |
$34,751.36 |
1.67% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
364 |
$34,634.60 |
1.67% |
| Teleflex Incorporated |
TFX |
879369106 |
288 |
$34,542.72 |
1.66% |
| Olympus Corporation |
7733.JP |
J61240107 |
2,940 |
$33,698.77 |
1.62% |
| Penumbra, Inc. |
PEN |
70975L107 |
138 |
$33,654.06 |
1.62% |
| Becton, Dickinson and Company |
BDX |
075887109 |
187 |
$33,192.50 |
1.60% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
1,934 |
$32,325.86 |
1.56% |
| Terumo Corporation |
4543.JP |
J83173104 |
1,860 |
$31,146.24 |
1.50% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
524 |
$30,287.20 |
1.46% |
| US Dollar |
$USD |
|
7,936 |
$7,936.49 |
0.38% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| New Zealand Dollar |
$NZD |
|
0 |
($0.01) |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|